US2011262501A1PendingUtilityA1
Osteoblast Stimulating Orthopedic Implant
Est. expiryMar 27, 2023(expired)· nominal 20-yr term from priority
A61L 31/126A61P 43/00Y10T29/49826A61L 27/303A61L 2430/32A61L 27/443A61L 2400/12A61L 31/084
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Nanomaterials for neural and orthopedic prostheses are disclosed. Composite carbon nanofibers enhance neuronal growth and minimize glial scar tissue formation. Methods and compositions to promote neuronal growth and minimize scar tissue formation during prolonged monitoring and treatment of neural tissue are disclosed. Composite polyurethane carbon nanofiber is a suitable material for neural implant. Composite carbon nanomaterials decrease adhesion of astrocytes and fibroblasts
Claims
exact text as granted — not AI-modified1 - 22 . (canceled)
23 . An orthopedic prostheses comprising an implantable device coated with a composite nanomaterial, said nanomaterial comprising a polymer matrix and carbon nanotubes having a width of about 2 to 200 nm, said device capable of stimulating osteoblast proliferation and minimizing fibroblast encapsulation.
24 . The orthopedic prosthesis of claim 23 wherein the carbon nanotubes have a width of about 10 to 100 nm and are functionalized with 4-hydroxynonenal.
25 . The orthopedic prostheses of claim 24 wherein substantially all of the carbon nanotubes are aligned with one another.
26 . The orthopedic prostheses of claim 23 wherein said polymer is selected from the group consisting of polyurethane, polymethacrylate, polyester, polyvinyl and any copolymers thereof.
27 . The orthopedic prostheses of claim 23 wherein the nanofibers are multi-walled nanotubes.
28 . A method of stimulating osteoblast proliferation and minimizing fibroblast encapsulation by an orthopedic implant in a patient, said method comprising:
(a) obtaining an orthopedic implant comprising a composite nanomaterial, said nanomaterial comprising a polymer matrix and carbon nanotubes, wherein the carbon nanotubes have a width of about 10 to 100 nm; and (b) securing the implantable device in said patient where proliferation of osteoblasts is desired.
29 . The method of claim 28 wherein said carbon nanotubes are functionalized with 4-hydroxynonenal.
30 . The method of claim 29 wherein substantially all of the carbon nanotubes are aligned with one another.
31 . The method of claim 30 wherein said polymer is selected from the group consisting of polyurethane, polymethacrylate, polyester, polyvinyl and any copolymers thereof.
32 . The method of claim 31 wherein the nanotubes are multi-walled nanotubes.
33 . The method of claim 28 wherein the composite nanomaterial comprises a polyurethane-carbon nanofiber composite, wherein said carbon nanofibers have a width of about 10 to 100 nm and are comprised of carbon nanotubes.
34 . A method of selecting a nanomaterial suitable for implant, the method comprising: (a) determining structural dimensions of a biological molecule in a biological tissue; and (b) fabricating the nanomaterial whose surface structural dimension is similar to the biological molecule.
35 . The method of claim 34 , wherein the nanomaterial comprises carbon nanofibers having a width of about 10 to 100 nm.
36 . The method of claim 34 , wherein the biological molecule is laminin.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.